← Open Payments lookup

MONICA SAM: Open Payments

NPI 1184115354 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,504 in 18 payments from 12 companies in 2025. Trend: 2023 $1,113 · 2024 $838 · 2025 $1,504

Food & beverage: $1,504
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.2$237
Axsome Therapeutics, Inc.2$201
Neurocrine BioSciences, Inc.1$133
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$126
Janssen Pharmaceuticals, Inc2$124
Verona Pharma, Inc.1$124
United Therapeutics Corporation2$120
Otsuka America Pharmaceutical, Inc.3$114
Abbott Laboratories1$97
Braeburn Inc.1$92

Products named: FANAPT, Auvelity, INGREZZA, CAPLYTA, INVEGA SUSTENNA, Ohtuvayre, TYVASO, REXULTI.

Industry payments across DE — which companies pay providers there.